pharmaceuticals

Cipla Ltd (CIPLA) Q2 FY22 Earnings Concall Transcript

● Nov 2, 2021

Cipla Limited (NSE: CIPLA) Q2 FY22 Earnings Concall dated Oct. 26, 2021 Corporate Participants: Naveen Bansal — Director, Finance Kedar Upadhye...

● Oct 29, 2021

Dr Reddy’s Laboratories (NSE: DRREDDY) reported its second-quarter financial results for the period ended September 30, 2021. The company had...

● Oct 26, 2021

The pharma giant Cipla (NSE: CIPL) reported its second-quarter 20223 earnings results on Tuesday after market hours. The total revenue...

● Sep 3, 2021

India’s domestic pharmaceutical market is estimated at $42 billion in 2021. It is likely to reach $65 billion by 2024...

● Jul 6, 2021

The pharmaceutical market in India was valued at $59 billion in 2020 and supplies over 50% globally for various vaccines....

● May 4, 2021

Alembic Pharmaceuticals Ltd. (NSE:APLLTD) Q4 FY21 Earnings Concall dated May 04, 2021

● Jan 29, 2021

Cipla Limited (NSE:CIPLA) Q3 FY21 earnings concall dated Jan. 29, 2021. Corporate Participants: Kumar Gaurav — Vice President, Kotak Institutional...

● Jan 19, 2021

Alembic Pharmaceuticals Limited (NSE:APLLTD) Q3 FY21 earnings concall dated Jan. 19, 2021. Corporate Participants: R. K. Baheti — Director –...